Treatment options for residual insomnia in schizophrenia

Acta Psychiatrica Scandinavica

Volumn 127, Issue 1, 2013, Pages 81-82

  Baandrup, Lone ^a   Jennum, Poul ^b   Lublin, Henrik ^a   Glenthoj, Birte ^a  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIPHENHYDRAMINE; DOXEPIN; MELATONIN; NEUROLEPTIC AGENT; PALIPERIDONE; QUETIAPINE; RISPERIDONE; TRAZODONE;

CIRCADIAN RHYTHM; COMORBIDITY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; INSOMNIA; LOW DRUG DOSE; MEDICAL HISTORY; METABOLIC DISORDER; NOTE; OFF LABEL DRUG USE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESIDUAL INSOMNIA; SCHIZOPHRENIA; SLEEP WAKING CYCLE; SOCIAL INTERACTION; SUBSTANCE ABUSE;

EID: 84871060558     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12016     Document Type: Note

References (5)

1. Haffmans P, Oolders J, Hoencamp E, Arends J. The effect of risperidone versus haloperidol on sleep patterns of schizophrenic patients - results of a double-blind, randomised pilot trial. Eur Neuropsychopharm 2001;11(Suppl. 3):S260.
2. Luthringer R, Staner L, Noel N et al. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol 2007;22:299-308.
3. Shamir E, Laudon M, Barak Y et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry 2000;61:373-377.
4. Shamir E, Rotenberg VS, Laudon M, Zisapel N, Elizur A. First-night effect of melatonin treatment in patients with chronic schizophrenia. J Clin Psychopharmacol 2000;20:691-694.
5. Suresh Kumar PN, Andrade C, Bhakta SG, Singh NM. Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study. J Clin Psychiatry 2007;68:237-241.